37th Annual Advances in Heart Disease


 

Lipoprotein(a) and CVD: Do Elevated Lp(a) Levels Contribute to CVD Risk? What Are the Effects of Statins, PCSK9-i, LDL Apheresis and ASOs Therapies?

January 29, 2021

7 Comments
Login to view comments. Click here to Login
Day 1